News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER-TLC announces public comment period for upcoming clinical trial
Patients, caregivers, and researchers will have 2 weeks to provide input on plans to test whether glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can help improve Long COVID symptoms.
Announcement
162 Results
162 Results
NIH to open Long COVID clinical trials to study sleep disturbances, exercise intolerance, and post-exertional malaise
RECOVER-ENERGIZE and RECOVER-SLEEP will test multiple treatments for sleep disturbances, difficulties exercising, and worsening Long COVID symptoms after physical, mental, or emotional activity.
News Release
NIH RECOVER makes Long COVID research data easier to access
De-identified data from thousands of adults with Long COVID are now available to researchers.
News Release
R3 Seminar Recap: PASC in Children: State of the Science and Future Directions
During the April 23rd, RECOVER Research Review (R3) Seminar, the speakers discussed our current knowledge of Long COVID in children, including epidemiology and risk factors, symptoms, underlying mechanisms that cause symptoms, and functional outcomes.
R3 Seminar Recap
R3 Seminar Recap: Patterns and Prevention of Long COVID: Findings from RECOVER EHR Cohort Studies
During the March 19th RECOVER Research Review (R3) Seminar, research presented findings about vaccine effectiveness against Long COVID in children and the association between SARS-CoV-2 infection and symptoms and conditions in children and adults.
R3 Seminar Recap
NIH opens Long COVID trials to evaluate treatments for autonomic nervous system dysfunction
RECOVER-AUTONOMIC will test at least three treatments for symptoms such as fast heart rate, dizziness and fatigue.
News Release
R3 Seminar Recap: Understanding Neurological Manifestations of PASC and Cerebral Vascular Injury
During the February 13th RECOVER Research Review (R3) Seminar, several pathobiology study awardees presented about the mechanisms of neurological (brain and nervous system) symptoms of Long COVID.
R3 Seminar Recap
Leadership Q&A: NIH to bolster RECOVER Long COVID research efforts
Gary Gibbons, M.D., Walter Koroshetz, M.D., and Jeanne Marrazzo, M.D., M.P.H. of the NIH answer questions about investing an additional $515 million in RECOVER's Long COVID research efforts.
Q&A
NIH to bolster RECOVER Long COVID research efforts through infusion of $515 million
This additional funding will build on and continue RECOVER's work to improve our understanding of and ability to diagnose, prevent, and treat Long COVID.
News Release